Title: A simple and accurate prediction model to estimate the intrahospital mortality risk of hospitalised cancer patients
Abstract: International Journal of Clinical PracticeVolume 58, Issue 11 p. 1014-1019 A simple and accurate prediction model to estimate the intrahospital mortality risk of hospitalised cancer patients H. Bozcuk, Corresponding Author H. Bozcuk Department of Medical Oncology,1Department of Internal Medicine,2Akdeniz University Medical Faculty, Antalya, Turkey *Dr Hakan Bozcuk, Akdeniz University Medical Faculty, Department of Medical Oncology, 07070 Antalya, Turkey Tel.: +90-242-2274343/33266 Fax: +90-242-2591454 Email: [email protected]Search for more papers by this author 1 E. Koyuncu, E. Koyuncu Department of Medical Oncology,1Department of Internal Medicine,2Akdeniz University Medical Faculty, Antalya, TurkeySearch for more papers by this author 2 M. Yildiz, M. Yildiz Department of Medical Oncology,1Department of Internal Medicine,2Akdeniz University Medical Faculty, Antalya, TurkeySearch for more papers by this author 1 M. Samur, M. Samur Department of Medical Oncology,1Department of Internal Medicine,2Akdeniz University Medical Faculty, Antalya, TurkeySearch for more papers by this author 1 M. ÖzdoǦan, M. ÖzdoǦan Department of Medical Oncology,1Department of Internal Medicine,2Akdeniz University Medical Faculty, Antalya, TurkeySearch for more papers by this author 1 M. ArtaÇ, M. ArtaÇ Department of Medical Oncology,1Department of Internal Medicine,2Akdeniz University Medical Faculty, Antalya, TurkeySearch for more papers by this author 1 E. Çoban, E. Çoban Department of Medical Oncology,1Department of Internal Medicine,2Akdeniz University Medical Faculty, Antalya, TurkeySearch for more papers by this author 2 B. SavaŞ, B. SavaŞ Department of Medical Oncology,1Department of Internal Medicine,2Akdeniz University Medical Faculty, Antalya, TurkeySearch for more papers by this author 1 H. Bozcuk, Corresponding Author H. Bozcuk Department of Medical Oncology,1Department of Internal Medicine,2Akdeniz University Medical Faculty, Antalya, Turkey *Dr Hakan Bozcuk, Akdeniz University Medical Faculty, Department of Medical Oncology, 07070 Antalya, Turkey Tel.: +90-242-2274343/33266 Fax: +90-242-2591454 Email: [email protected]Search for more papers by this author 1 E. Koyuncu, E. Koyuncu Department of Medical Oncology,1Department of Internal Medicine,2Akdeniz University Medical Faculty, Antalya, TurkeySearch for more papers by this author 2 M. Yildiz, M. Yildiz Department of Medical Oncology,1Department of Internal Medicine,2Akdeniz University Medical Faculty, Antalya, TurkeySearch for more papers by this author 1 M. Samur, M. Samur Department of Medical Oncology,1Department of Internal Medicine,2Akdeniz University Medical Faculty, Antalya, TurkeySearch for more papers by this author 1 M. ÖzdoǦan, M. ÖzdoǦan Department of Medical Oncology,1Department of Internal Medicine,2Akdeniz University Medical Faculty, Antalya, TurkeySearch for more papers by this author 1 M. ArtaÇ, M. ArtaÇ Department of Medical Oncology,1Department of Internal Medicine,2Akdeniz University Medical Faculty, Antalya, TurkeySearch for more papers by this author 1 E. Çoban, E. Çoban Department of Medical Oncology,1Department of Internal Medicine,2Akdeniz University Medical Faculty, Antalya, TurkeySearch for more papers by this author 2 B. SavaŞ, B. SavaŞ Department of Medical Oncology,1Department of Internal Medicine,2Akdeniz University Medical Faculty, Antalya, TurkeySearch for more papers by this author 1 First published: 18 August 2004 https://doi.org/10.1111/j.1742-1241.2004.00169.xCitations: 31Read the full textAboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onEmailFacebookTwitterLinkedInRedditWechat Summary We aimed to form a risk prediction model to assess the probability of intrahospital death in cancer patients at the time of hospitalisation. The medical records and the relevant clinical parameters of cancer patients who died in or who were discharged from a teaching hospital between 1997 and 2000 (n = 334) were reviewed to explore the determinants of intrahospital death, which later were verified prospectively (n = 131). Eastern Cooperative Oncology Group (ECOG) performance status of four, short duration of disease (on a logarithmic scale), emergency admission, low haemoglobin (Hb) value (on a linear scale) and lactate dehydrogenase (LDH) value greater than 378 µ/ml were significantly and independently associated with the risk of intrahospital death. This model had a receiver operating characteristic area of 0.88 in the derivation cohort and 0.82 in the validation cohort. Using readily available clinical parameters, it is possible to devise an accurate and applicable risk prediction model for the hospitalised cancer patients. References 1 McCarthy EP, Phillips RS, Zhong Z et al. Dying with cancer: patients' function, symptoms, and care preferences as death approaches. J Am Geriatr Soc 2000; 48 (5): 110–21. 10.1111/j.1532-5415.2000.tb03120.x CASPubMedWeb of Science®Google Scholar 2 Gasinska A, Urbanski K, Adamczyk A et al. Prognostic significance of intratumour microvessel density and haemoglobin level in carcinoma of the uterine cervix. Acta Oncol 2002; 41 (5): 437–43.DOI: 10.1080/028418602320405023 10.1080/028418602320405023 PubMedWeb of Science®Google Scholar 3 Smaletz O, Scher HI, Small EJ et al. Nomogram for overall survival of patients with progressive metastatic prostate cancer after castration. J Clin Oncol 2002; 20 (19): 3972–82.DOI: 10.1200/JCO.2002.11.021 10.1200/JCO.2002.11.021 PubMedWeb of Science®Google Scholar 4 Tas F, Aykan F, Alici S et al. Prognostic factors in pancreatic carcinoma: serum LDH levels predict survival in metastatic disease. Am J Clin Oncol 2001; 24 (6): 547–50.DOI: 10.1097/00000421-200112000-00003 10.1097/00000421-200112000-00003 CASPubMedWeb of Science®Google Scholar 5 Sculier JP, Paesmana M, Markiewicz E et al. Scoring systems in cancer patients admitted for an acute complication in a medical intensive care unit. Crit Care Med 2000; 28 (8): 2786–92.DOI: 10.1097/00003246-200008000-00018 10.1097/00003246-200008000-00018 CASPubMedWeb of Science®Google Scholar 6 Teno JM, Harrell FE Jr, Knaus W et al. Prediction of survival for older hospitalised patients: the HELP survival model. Hospitalised Elderly Longitudinal Project. J Am Geriatr Soc 2000; 48 (5): 16–24. 10.1111/j.1532-5415.2000.tb03126.x Google Scholar 7 Knaus WA, Harrell FE Jr, Lynn J et al. The SUPPORT prognostic model. Objective estimates of survival for seriously ill hospitalised adults. Study to understand prognoses and preferences for outcomes and risks of treatments. Ann Intern Med 1995; 122 (3): 191–203. 10.7326/0003-4819-122-3-199502010-00007 CASPubMedWeb of Science®Google Scholar 8 Staudinger T, Stoiser B, Mullner M et al. Outcome and prognostic factors in critically ill cancer patients admitted to the intensive care unit. Crit Care Med 2000; 28 (5): 1322–8.DOI: 10.1097/00003246-200005000-00011 10.1097/00003246-200005000-00011 CASPubMedWeb of Science®Google Scholar 9 Argiris A, Murren JR. Staging and clinical prognostic factors for small-cell lung cancer. Cancer J 2001; 7 (5): 437–47. CASPubMedWeb of Science®Google Scholar 10 Toner GC, Geller NL, Lin SY et al. Extragonadal and poor risk nonseminomatous germ cell tumours. Survival and prognostic features. Cancer 1991; 67 (8): 2049–57. 10.1002/1097-0142(19910415)67:8<2049::AID-CNCR2820670807>3.0.CO;2-H PubMedWeb of Science®Google Scholar 11 Vollmer RT, Kantoff PW, Dawson NA et al. Importance of serum hemoglobin in hormone refractory prostate cancer. Clin Cancer Res 2002; 8 (4): 1049–53. PubMedWeb of Science®Google Scholar 12 Ohara T, Takahashi M, Yamanaka H et al. Serum lactate dehydrogenase and CD4+/CD8+ lymphocyte ratio predict survival in terminally ill cancer patients. Gan To Kagaku Ryoho 2002; 29 (10): 1779–83. PubMedGoogle Scholar 13 Biasi F, Chiarpotto E, Lanfranco G et al. Oxidative stress in the development of human ischemic hepatitis during circulatory shock. Free Radic Biol Med 1994; 17 (3): 225–33. 10.1016/0891-5849(94)90078-7 CASPubMedWeb of Science®Google Scholar 14 Hardaway RM. Prediction of survival or death of patients in a state of severe shock. Surg Gynecol Obstet 1981; 152 (2): 200–6. CASPubMedWeb of Science®Google Scholar 15 Li C, Wright MM, Jackson RM. Reactive species mediated injury of human lung epithelial cells after hypoxia-reoxygenation. Exp Lung 2002; 28 (5): 373–89.DOI: 10.1080/01902140290092001 10.1080/01902140290092001 Web of Science®Google Scholar 16 Groeger JS, Lemeshow S, Price K et al. Multicenter outcome study of cancer patients admitted to the intensive care unit: a probability of mortality model. J Clin Oncol 1988; 16 (2): 761–70. Google Scholar 17 Maltoni M, Nanni O, Pirovano M et al. Successful validation of the Palliative prognostic score in terminally ill cancer patients. J Pain Symptom Manage 1999; 17 (4): 240–7.DOI: 10.1016/S0885-3924(98)00146-8 10.1016/S0885-3924(98)00146-8 CASPubMedWeb of Science®Google Scholar 18 Allard P, Dionne A, Potvin D. Factors associated with length of survival among 1081 terminally ill cancer patients. J Palliat Care 1995; 11 (3): 20–4. CASPubMedWeb of Science®Google Scholar 19 Bozcuk H, Martin C. Does treatment delay affect survival in non-small cell lung cancer? A retrospective analysis from a single UK centre. Lung Cancer 2001; 34 (2): 243–52. 10.1016/S0169-5002(01)00247-1 CASPubMedWeb of Science®Google Scholar 20 Kattan M. Statistical prediction models, artificial neural networks, and the sophism ‘I am a patient, not a statistic’. J Clin Oncol 2002; 20 (4): 885–7. PubMedWeb of Science®Google Scholar Citing Literature Volume58, Issue11November 2004Pages 1014-1019 ReferencesRelatedInformation